Economy

Injectable drugs and in-patient care drive the highest of cost for employers.

Megan Cook left a traditional brokerage to launch her own firm targeted at changing the way employers approach medical benefits.

The final ruling includes protections intended to remedy historical challenges with AHPs and to prevent AHPs from discriminating against individuals based on health reasons.

The online retail giant’s purchase of the e-pharmacy may deliver convenience but who will monitor customers for side effects and wrong dosages?

In the first 10 days of July, at least ten drugmakers and biotechnology companies have raised prices on at least 20 brand-name medicines.

After the Cincinnati bank started a personal assistant service for new mothers, it learned new parents needed help with budgeting, and that motivated it to team up with a Goldman Sachs firm to establish a financial wellness program for all its employees.

In an effort to bring insurance carriers back to ACA exchanges, the U.S. government is increasing funding to insurers, which could spur brokers to recommend the exchanges to clients.

As the new head of Amazon, Berkshire and JPMorgan’s healthcare venture gets down to work, we can see what his plans might be for the future of large employer health plans.

The move by CMS may affect publicly traded insurers that have stuck with the ACA.